vVARDIS Announces Investment from Apollo —Achieves Unicorn Status

Contributed by: Business Wire

Images

Photo credit: Jos Schmid, Photographer
Photo credit: Jos Schmid, Photographer
Photo credit: Dr. Mehrdad Razaghy, DDS
Photo credit: Dr. Mehrdad Razaghy, DDS
Business Wire embedded0

Tags

Professional Services
Medical Supplies
Health
Health Technology
Dental
Asset Management
Biotechnology
Investment

More Like This

vVARDIS Announces Investment from Apollo —Achieves Unicorn Status

vVARDIS Founders Present Drill-Free Early Cavity Treatment and Unveil Global Cavity Awareness Campaign at the 2026 J.P. Morgan Healthcare Conference

vVARDIS Advances Sustainable, Drill-Free Caries Management Consistent With WHO’s Forward-Looking Vision for Environmentally Friendly Oral Health

ACCESS Newswire associated0

DEXIS to Showcase Cutting-Edge Innovations at IDS 2025

PR Newswire associated0

VentureMed Group Closes $28M Series C Funding to Accelerate Commercial Adoption and Expand Indications for the FLEX VPTM System

Business Wire logo

Nordic Pharma Group B.V. Through Its Subsidiary Amring Pharmaceuticals Inc., Completes Acquisition of Visant Medical to Launch Novel Therapy for Dry Eye Disease in the United States

Business Wire logo

Crescent European Specialty Lending Provides Financing to Support Apheon-Led Buy-and-Build Platform in Trenchless Pipe Rehabilitation Market

PR Newswire associated0

Novadip Biosciences SA announces significant clinical milestones for both of its clinical-stage programs